Literature DB >> 17359303

TACC3 is required for the proper mitosis of sclerotome mesenchymal cells during formation of the axial skeleton.

Ryoji Yao1, Yasuko Natsume, Tetsuo Noda.   

Abstract

Transforming acidic coiled-coil-containing (TACC) family members regulate mitotic spindles and have essential roles in embryogenesis. However, the functions of TACC3 in mitosis during mammalian development are not known. We have generated and characterized three mutant alleles of mouse Tacc3 including a conditional allele. Homozygous mutants of a hypomorphic allele exhibited malformations of the axial skeleton. The primary cause of this defect was the failure of mitosis in mesenchymal sclerotome cells. In vitro, 36% of primary mouse embryo fibroblasts (MEF) obtained from mutants homozygous for the hypomorphic allele and 67% of MEF from Tacc3 null mutants failed mitosis. In cloned immortalized MEF, Tacc3 depletion destabilized spindles and prevented chromosomes from aligning properly. Furthermore, chromosome separation and cytokinesis were also severely impaired. Chromosomes were moved randomly and cytokinesis initiated but the cleavage furrow eventually regressed, resulting in binucleate cells that then yielded aneuploid cells in the next cell division. Thus, in addition to spindle assembly, Tacc3 has critical roles in chromosome separation and cytokinesis, and is essential for the mitosis of sclerotome mesenchymal cells during axial formation in mammals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359303     DOI: 10.1111/j.1349-7006.2007.00433.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  14 in total

1.  TACC3 protein regulates microtubule nucleation by affecting γ-tubulin ring complexes.

Authors:  Puja Singh; Geethu Emily Thomas; Koyikulangara K Gireesh; Tapas K Manna
Journal:  J Biol Chem       Date:  2014-09-22       Impact factor: 5.157

2.  Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells.

Authors:  R Yao; J Oyanagi; Y Natsume; D Kusama; Y Kato; S Nagayama; T Noda
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

3.  TACC3 is essential for EGF-mediated EMT in cervical cancer.

Authors:  Geun-Hyoung Ha; Jung-Lye Kim; Eun-Kyoung Breuer; Eun-Kyoung Yim Breuer
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

4.  The centrosomal adaptor TACC3 and the microtubule polymerase chTOG interact via defined C-terminal subdomains in an Aurora-A kinase-independent manner.

Authors:  Harish C Thakur; Madhurendra Singh; Luitgard Nagel-Steger; Jana Kremer; Daniel Prumbaum; Eyad Kalawy Fansa; Hakima Ezzahoini; Kazem Nouri; Lothar Gremer; André Abts; Lutz Schmitt; Stefan Raunser; Mohammad R Ahmadian; Roland P Piekorz
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

5.  Regulation of interkinetic nuclear migration by cell cycle-coupled active and passive mechanisms in the developing brain.

Authors:  Yoichi Kosodo; Taeko Suetsugu; Masumi Suda; Yuko Mimori-Kiyosue; Kazunori Toida; Shoji A Baba; Akatsuki Kimura; Fumio Matsuzaki
Journal:  EMBO J       Date:  2011-03-25       Impact factor: 11.598

6.  Xenopus TACC1 is a microtubule plus-end tracking protein that can regulate microtubule dynamics during embryonic development.

Authors:  Christopher M Lucaj; Matthew F Evans; Belinda U Nwagbara; Patrick T Ebbert; Charlie C Baker; Joseph G Volk; Andrew F Francl; Sean P Ruvolo; Laura Anne Lowery
Journal:  Cytoskeleton (Hoboken)       Date:  2015-05

7.  Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.

Authors:  N Ohoka; K Nagai; T Hattori; K Okuhira; N Shibata; N Cho; M Naito
Journal:  Cell Death Dis       Date:  2014-11-06       Impact factor: 8.469

Review 8.  Translational control by cytoplasmic polyadenylation in Xenopus oocytes.

Authors:  Helois E Radford; Hedda A Meijer; Cornelia H de Moor
Journal:  Biochim Biophys Acta       Date:  2008-02-14

9.  TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.

Authors:  Dong-Sheng Zhou; Hong-Bo Wang; Zhong-Guo Zhou; Yao-Jun Zhang; Qian Zhong; Li Xu; Yue-Hua Huang; Sai-Ching Yeung; Min-Shan Chen; Mu-Sheng Zeng
Journal:  Oncotarget       Date:  2015-09-15

10.  The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis.

Authors:  Chia-Feng Liu; Véronique Lefebvre
Journal:  Nucleic Acids Res       Date:  2015-07-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.